Previous Article | Next Article 
Journal of Clinical Microbiology, March 2001, p. 1097-1104, Vol. 39, No. 3
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.1097-1104.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antimicrobial Resistance and Bacterial
Identification Utilizing a Microelectronic Chip Array
Lorelei
Westin,1
Carolyn
Miller,2,*
Dana
Vollmer,2
David
Canter,3
Ray
Radtkey,3
Michael
Nerenberg,3,
and
James
P.
O'Connell1
Departments of Advanced
Research,1 Assay
Development,2 and Molecular
Biology,3 Nanogen, Inc., San Diego, California
Received 31 July 2000/Returned for modification 19 September
2000/Accepted 8 December 2000
 |
ABSTRACT |
Species-specific bacterial identification of clinical specimens is
often limited to a few species due to the difficulty of performing
multiplex reactions. In addition, discrimination of amplicons is
time-consuming and laborious, consisting of gel electrophoresis, probe hybridization, or sequencing technology. In order to simplify the
process of bacterial identification, we combined anchored in situ
amplification on a microelectronic chip array with discrimination and
detection on the same platform. Here, we describe the simultaneous amplification and discrimination of six gene sequences which are representative of different bacterial identification assays:
Escherichia coli gyrA, Salmonella gyrA,
Campylobacter gyrA, E. coli parC, Staphylococcus mecA, and Chlamydia
cryptic plasmid. The assay can detect both plasmid and transposon genes
and can also discriminate strains carrying antibiotic resistance
single-nucleotide polymorphism mutations. Finally, the assay is
similarly capable of discriminating between bacterial species through
reporter-specific discrimination and allele-specific
amplification. Anchored strand displacement amplification allows
multiplex amplification and complex genotype discrimination on the same
platform. This assay simplifies the bacterial identification process
greatly, allowing molecular biology techniques to be performed with
minimal processing of samples and practical experience.
 |
INTRODUCTION |
Genotype identification has been
widely recognized as an effective tool in the identification and
characterization of infectious disease organisms (7, 12,
16). Molecular biology-based bacterial identification assays
have the potential of decreasing the time necessary for and increasing
the specificity of bacterial determinations, making them efficacious
alternatives to traditional biochemical and microbiological culture
techniques. For example, Chlamydia trachomatis and
Mycobacterium tuberculosis are traditionally very difficult
organisms to culture. Molecular biology techniques circumvent the need
for long culturing protocols by using amplification of either DNA (PCR,
ligase chain reaction [LCR], strand displacement amplification
[SDA], and nucleic acid sequence-based amplification [NASBA]) or RNA (reverse transcription-PCR, NASBA, reverse
transcription-SDA, and transcription-mediated amplification [TMA])
targets. However, molecular biology techniques are also
advantageous because of the amount of information that can be obtained
from a single assay in a short period of time. As a result, the 1999 National Committee for Clinical Laboratory Standards
(13a) guidelines have for the first time mandated
the use of molecular biology methods in clinical laboratories that
perform bacterial identification assays.
There are many examples of molecular biology-based assays used in the
laboratory. Genotypic identification of bacterial samples is used to
discriminate and identify bacteria at either the genus, species, or
strain level (1, 9). Genotypic identification of
antimicrobial resistance is also used as an aid in the treatment of infectious diseases (15, 19, 20, 24). Conventional antimicrobial susceptibility testing provides only phenotypic profiling of a potential pathogen. Low-level antimicrobial
activity and heterogeneous populations of antimicrobial
agent-resistant pathogens are difficult to detect with these
techniques. Molecular analysis of pathogens provides a more definite
means of obtaining the antimicrobial status of microorganisms by
identifying organisms that possess the genetic material necessary for resistance.
As with all amplification assays, multiplex target or signal
amplification is difficult. There have been numerous reports of
multiplex PCR assays developed for many bacterial identification assays
(15, 20). However, multiplex PCR assays, as well as all
other target and signal amplification assays, are still
limited in the amounts of templates that can be amplified
simultaneously because of the difficulty of optimizing primer and
reagent conditions. In addition, discrimination of closely
matched amplicon sequences is time-consuming and laborious, consisting
of either gel electrophoresis, probe hybridization, or sequencing technology.
Microchip arrays are capable of analyzing hundreds to thousands of
different loci simultaneously in a relatively short period of time
(3, 13). However, most microchip array systems require large amounts of template DNA, or targets from multiplex
amplification, in order to detect DNA or RNA at fairly low
levels (2, 13). We recently described an assay on an
electronic microchip array which was capable of multiplex amplification
of 10 targets simultaneously, with little decrease in amplification
efficiency (22). Anchored SDA on microelectronic chips
encompasses amplification on the surface of the array, requiring very
small amounts of input DNA. The flexibility of the microelectronic chip
array has been demonstrated repeatedly in many types of genetic
discrimination assays, including single-nucleotide polymorphism
(SNP) (8, 18) and short tandem repeat (17)
discrimination assays. Here, we describe an in situ amplification assay
using complex genomic DNA samples on a microelectronic chip
array. We have also combined amplification with genetic discrimination assays for the identification of bacterial species and antimicrobial resistance and for SNP discrimination of fluoroquinolone resistance in
Campylobacter isolates. This technology greatly simplifies molecular genotyping assays by requiring substantially less sample processing and technical expertise than most molecular biology-based assays.
 |
MATERIALS AND METHODS |
Strains, culture conditions, and isolation of
genomic DNA.
Bacterial strains were obtained from various
sources, including the American Type Culture Collection (Manassas,
Va.), the Centers for Disease Control and Prevention (Atlanta, Ga.),
the National Cell and Tissue Collection, and BD Biosciences
(Hunt Valley, Md.). All bacterial species were cultured as recommended by the American Type Culture Collection. Genomic DNA was isolated from
liquid culture cells or plate scrapings using DNeasy genomic DNA isolation kits (Qiagen, Valencia, Calif.). All amplification systems were tested with at least three different strains.
SDA primers.
Oligonucleotides (Table
1) were synthesized at Integrated DNA
Technologies (Coralville, Iowa). Oligonucleotides were coupled with either BODIPY Texas red (BTR), Cy3, or Cy5 fluorophore or biotin at the 5' end.
Microelectronic chips, amplification primer deposition, and
hybridization of templates.
Microelectronic chips and the
permeation layer were prepared as described previously (5,
8). In brief, the APEX chip used for these experiments
consists of a 5- by 5-array of 80-µm circular microelectrodes with
200-µm microelectrodes at each corner of the array. Chips were
mounted on a micromanipulator stage, and the microelectrodes were
activated by a power supply and appropriately controlled relay
switches. All electronic manipulations on the microchip were done in 50 mM histidine buffer. Biotinylated, BTR-labeled T12
oligonucleotide [BTR-dT(12)] was used as a control for
streptavidin integrity in the permeation layer. All SDA primers were
coupled with biotin at the 5' terminus. After hydration of the
microchip in 50 mM histidine buffer, SDA primer sets were
electronically addressed (0.8 µA/site, pulsed for 1 min) to specific
array sites as indicated in each experiment. The chips were washed with
50 mM histidine buffer between each application of oligonucleotide sets. The SDA primers were then electronically hybridized with genomic DNA templates (0.8 µA/site, pulsed for 3.5 min). The
chips were washed with water after hybridization with the templates, incubated in a 100-µg/ml bovine serum albumin solution for 10 to 30 min at room temperature, and washed again with water.
Anchored SDA.
Figure 1 is a
schematic representation of anchored SDA. For simplicity, only one
strand is shown in the illustration. Biotinylated primers were first
electronically addressed to individual locations on the microchip array
(Fig. 1, panel I) as mentioned above. Templates were then
electronically hybridized to the biotinylated primers, and the
amplification reaction was initiated with the addition of bumper
primers and enzymes (Fig. 1, panel II). This step was performed by
preheating the microchips to 60°C for 5 min in a humidifying chamber.
The water was removed and replaced with 10 µl of prewarmed SDA
mixture (6 mM morpholinepropanesulfonic acid [MOPS] [pH 7.8]; 1.7 mM [each] dCTP [thiolated], dTTP, dATP, and dGTP; 85 mM KCl;
18 mM MgCl2; 23 mM NaCl; 3.5 mM Tris-HCl [pH 7.9]; 0.035 mM dithiothreitol; 1.5 U of BsoBI; 0.8 U of
BstI polymerase; 25 nM each bumper primer)
(21). The microchips were incubated for 30 min at 60°C
in a humidifying chamber. The reaction was stopped by removing the
chips and washing them approximately five times with 0.5× SSC (1× SSC
is 0.075 M NaCl plus 0.0075 M sodium citrate [pH 7.2]) at room
temperature.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representation of anchored SDA and bacterial
discrimination. Biotinylated SDA amplification primer sets are first
addressed to spatially distinct areas on the microchip array using
electronic biasing. Templates are then electronically hybridized to the
SDA primer sets, and the SDA reaction is performed in situ with the
addition of bumper primers and reaction reagents to the microchip
(panel I). The amplification primers contain a BsoBI
restriction endonuclease site, essential for SDA. The bumper primers
(not shown) are needed only to remove the initial primer extension
product from the target template, allowing the primer-extended strand
to bind to its complementary amplification primer. Primer extension of
the complementary amplification primer and subsequent incorporation of
a thiolated nucleotide (dCTP) over the BsoBI site induce
nicking by BsoBI in the amplification primer region. The
presence of a nick signals polymerase binding and simultaneous strand
displacement-primer extension, resulting in exponential amplification
of the target DNA. The SDA reaction is stopped by removal of the
supernatant, double-stranded DNA products are denatured on the
microchip, and internal reporters are hybridized to the amplicon
products remaining on the chip (panel II). Discrimination is performed
by increasing heat (thermal stringency) until only one reporter species
(Cy3 or Cy5) remains (panel III). wt, wild type.
|
|
After amplification, the anchored amplicons were denatured with the
addition of an alkali solution (0.5× SSC, pH 12.5, 4 min)
and washed
five times at room temperature (0.5× SSC, pH 7.2).
The amplicons were
then hybridized with 1.0 µM stabilizer oligonucleotides
in 4× SSC
(pH 7.2) at room temperature for 3 min. After extensive
washing (5 to
10 times) with 0.5× SSC, a 0.5 µM concentration
of reporter
oligonucleotides was hybridized for 5 min in 4× SSC
at room
temperature (Fig.
1, panel III). The reporters were coupled
at the 5'
end with either Cy3, Cy5, or BTR fluorophore. Extensive
washing (5 to
10 times) with 0.5× SSC (pH 7.2), followed by 0.2×
SSC-1.0% sodium
dodecyl sulfate and 0.2× SSC washes at room temperature,
removed most
of the unbound reporter oligonucleotides. Temperature
stringency in 50 mM NaPO
4 (pH 7.7) was applied to discriminate
SNPs and other closely matched reporters. Temperature was ramped
up in
3°C increments and maintained for at least 3 min at each
step. Images
were taken at every step, and the microchips were
washed with 50 mM
NaPO
4 (pH 7.7) at every temperature interval.
The
entire assay from template hybridization to reporter discrimination
took approximately 70 to 90 min, depending on the number of templates
to be hybridized on the microchip
array.
Reporter discrimination using base-stacking energy transfer.
One of the advantages of anchored SDA lies in its ability to amplify
and detect target DNA on the same platform. Achieving amplification of
and discrimination between very similar DNA targets is difficult to
accomplish with a single-platform assay. We took advantage of
base-stacking energy transfer techniques to assist in reporter
discrimination of SNPs (14, 17, 23). Amplification primers
were designed surrounding the Thr86Ile mutation in the gyrase A region
of type II DNA topoisomerase in Campylobacter jejuni; this
mutation was previously shown to confer fluoroquinolone resistance in
bacteria carrying it (24). Base-stacking reporters were used such that the 5' end of the labeled reporter would base stack
alongside a longer stabilizer oligonucleotide (14, 17, 23). If the amplified target presented a perfect match to the labeled reporter, then the base-stacking energies between the stabilizer oligonucleotide and the labeled reporter would be favorable, allowing the shorter reporter to remain hybridized to the amplified target at elevated temperatures. However, if the amplified target presented a mismatch to the labeled reporter, then the base-stacking energy of the stabilizer oligonucleotide would be absent, allowing removal of the labeled reporter at elevated temperatures. In order to
distinguish the presence of the Thr86Ile mutation, two reporters were
designed, with either a Cy3 or a Cy5 fluorophore label coupled at the
5' end. The wild-type reporter, with the wild-type C at the 5' end, was
end labeled with Cy3, whereas the mutant reporter, with a T at the 5'
end, was end labeled with Cy5. After temperature stringency steps were
applied to the amplified product on the microelectronic chip array, the
genotype could be determined by noting the fluorophore type remaining
on the microchip.
 |
RESULTS |
Chlamydia identification using a plasmid-dependent gene.
C. trachomatis was amplified by anchored SDA using
primers to the cryptic plasmid as the target sequence
(10). Figure 2 shows the
results of a titration experiment with various amounts of
Chlamydia template input. Noncleavable primers, which have a
single base mutation in the recognition site for BsoBI, were used as a control for background binding of hybridized template and to
ensure that amplification was occurring on the microchip surface
(22). Template input levels of 1,000 copies of DNA could be routinely detected using anchored SDA in multiple experiments. Template input levels of 100 copies gave variable results (data not
shown), indicating the threshold of amplification to be between 100 and
1,000 copies of plasmid DNA. No amplification could be detected when
other bacterial sources were hybridized to the Chlamydia SDA
primers (Table 1), indicating a high specificity of amplification. The
latter is due to both the specificity of the SDA primers for amplification and the specificity of the reporter oligonucleotide for
hybridization to the correct amplicon.

View larger version (134K):
[in this window]
[in a new window]
|
FIG. 2.
Amplification of C. trachomatis cryptic
plasmid by anchored SDA. Anchored SDA was performed with increasing
amounts of template DNA input to determine the sensitivity of the
system. Representative fluorescent images of each titration reaction
are made after reporter hybridization and washing. Gray bars show SDA
primers; white bars show mutated SDA primers for control of template
background binding (noncleavable; bars are barely visible above the
x axis).
|
|
Antimicrobial resistance discrimination using anchored SDA.
Staphylococcus aureus methicillin resistance was used as a
model system for antimicrobial resistance determination with a novel
gene insertion mechanism. In this experiment, genomic DNA from
cultured methicillin-sensitive and methicillin-resistant S. aureus was purified and hybridized to the microelectronic chip array. As shown in Fig. 3a, only S. aureus samples that have been characterized as methicillin
resistant showed any positive signal. An anchored SDA system from the
human factor V gene (22) was used as a control to show
that amplification was functional in the methicillin-sensitive
amplification reaction. These results demonstrate the specificity and
accuracy of anchored SDA.


View larger version (173K):
[in this window]
[in a new window]
|
FIG. 3.
(a) Detection of the mecA gene in
S. aureus by anchored SDA. Anchored SDA was performed
with either methicillin-susceptible (Staph aureus) or
methicillin-resistant (MRSA) S. aureus
genomic DNA. Factor V-anchored SDA was performed on the same
microchip array as a control for the efficiency of the anchored SDA
reaction. (b) Discrimination of fluoroquinolone-resistant C.
jejuni using anchored SDA. Anchored SDA was performed with 50 ng of C. jejuni genomic DNA samples expressing a
wild-type phenotype (wt; top fluorescent image) or containing a
fluoroquinolone-resistant point mutation (CS34; bottom fluorescent
image). Wild-type reporters (Cy3) and fluoroquinolone-resistant mutant
reporters (Cy5) were hybridized to the microchip array, and thermal
stringency was applied to discriminate the amplification reaction.
Reporter signals remaining after thermal stringency were quantified to
determine the genotype of the hybridized genomic DNA sample
(graph). init, initial temperature; 27, 27°C.
|
|
Targeting of critical proteins used by antimicrobial agents to access
bacterial cells can also confer antibiotic resistance.
We tested our
system by using an SNP, recently found in
C. jejuni samples
(
24), which confers resistance against fluoroquinolone
antibiotics by interfering with the putative active site of gyrase
A
(
4). Figure
3b shows the results of amplification with
either
wild-type genomic DNA or genomic DNA from
clinical isolate samples
with a confirmed fluoroquinolone resistance
mutation at the C
position of codon 86 (
24). Amplification
with wild-type genomic
DNA resulted in only the wild-type Cy3
reporter remaining on targeted
microchip sites, indicating the correct
discrimination pattern.
However, if genomic DNA from, in this
example, CS34 was used for
target amplification, only the mutant Cy5
reporter remained on
the microchip electrode sites, again indicating
the correct discrimination
pattern. Two other clinical isolates with a
confirmed SNP at the
same site, CS5 and CS50 (
24), were
also used as target sources,
with identical results (data not shown).
These results demonstrate
the ability to perform both amplification and
complex genotyping
discrimination on the same
platform.
E. coli and Salmonella discrimination
using anchored SDA.
Bacterial gyrase A genes have been extensively
studied as a model system for molecular phylogenetic reconstruction due
to the presence of highly conserved motifs interspersed with regions of
divergent sequences (11). This relatively conserved
sequence organization allows for the design of common amplification
primers for amplification of bacterial sequences, followed by the use of specific reporters for bacterial identification discrimination assays. We used sequences from the gyrA region of type II
DNA topoisomerase to amplify and discriminate E. coli and
Salmonella genomic DNAs in our assay (Fig.
4). The SDA primers were designed on the
basis of a region that is conserved between E. coli and Salmonella, allowing both organisms to be amplified if
present in a sample. Campylobacter,
Chlamydia, and S. aureus genomic DNAs were not amplified using this set of SDA primers (Table 1).
After amplification of the samples, microchips were hybridized with base-stacking reporters specific for either E. coli (Cy3) or
Salmonella (Cy5). As shown in Fig. 4, the correct signal was
dependent on the input DNA origin. Only a Cy3 signal could be seen when
E. coli was used as the DNA template for amplification. In
contrast, only a Cy5 signal could be seen when Salmonella
was used as the DNA template. The assay was repeated with six other
Salmonella samples and seven other E. coli
samples, with identical results (data not shown).

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 4.
E. coli and Salmonella
bacterial identification using reporter-specific and allele-specific
SDA primers. A duplex anchored SDA was performed to identify E.
coli and Salmonella genomic DNA samples
after amplification. Amplification primers for parC and
gyrA amplifications were addressed to separate locations
on the microchip array. Approximately 100 pg of E. coli
and Salmonella genomic DNA was addressed to all
primer sets and hybridized with reporters for both E. coli
gyrA and parC and Salmonella gyrA
amplicons. Reporter signals remaining after application of thermal
stringency were quantified to determine the genotype of the hybridized
genomic DNA sample (graph). N/C, noncleavable.
|
|
Reporter discrimination is a relatively straightforward
method for bacterial identification assays. However,
discrimination
can also be designed into amplification primers,
allowing amplification
of one set of sequences but not others.
Allele-specific amplification
has been demonstrated previously using
SDA (
6). We combined
both reporter discrimination and
allele-specific amplification
in the same assay to provide a more
flexible and secure means
of bacterial identification. In addition to
reporter discrimination
of
E. coli and
Salmonella, Fig.
4 also demonstrates the use of
allele-specific amplification of
E. coli and
Salmonella genomic
DNA samples with amplification
primers from the
parC region of
type II DNA topoisomerase.
The
parC amplification primers were
designed such that
E. coli but not
Salmonella samples would be
amplified. As shown in Fig.
4 (graph), only
E. coli samples
amplified
a product when hybridized to
parC amplification
primers. No product
could be detected for
Salmonella
genomic DNA samples, either on
the microchip array or in
solution SDA assays using polyacrylamide
gels for visualizing amplicon
products (data not
shown).
Assay sensitivity and cross-reactivity with other bacterial
genomic DNAs.
Table 2 lists
the sensitivities of the amplification systems as well as the
cross-reactivity of other bacterial genomic DNAs with each
primer set. Since these primer sets were not optimized, the levels of
sensitivity differed for the systems. Campylobacter gyrA and
E. coli or Salmonella gyrA amplification
primers were the most sensitive, with detection occurring at 100 copies
of template input. Chlamydia cryptic plasmid and
Staphylococci mecA amplification primers were next, needing
approximately 1,000 copies for successful amplification. The least
sensitive system was for the E. coli parC gene, needing at
least 10,000 copies for successful amplification. Genomic DNAs from 10 other bacterial sources were tested for cross-reactivity. None of the
primer sets exhibited any level of amplification with these
genomic DNA sources.
Multiplex amplification.
Although antimicrobial resistance and
strain discrimination are important in molecular diagnostic assays, it
would be ideal to have a high-throughput assay that can screen a large
number of genes simultaneously. In order to demonstrate this concept, the maximum numbers of amplification systems for a 25-site microchip array, with the proper controls, were amplified simultaneously. E. coli, C. jejuni, methicillin-resistant
S. aureus, and Chlamydia cryptic plasmid
genomic DNAs were hybridized to the microchip array and
amplified simultaneously. As shown in Fig.
5, all systems amplified simultaneously,
giving correct discrimination patterns for the template DNA inputs
used. Quantification of the signals (Fig. 5, graph) showed that the
least sensitive system (parC) (Table 1) also amplified
poorly in the multiplex amplification situation, whereas the most
sensitive system (E. coli or Salmonella gyrA and Campylobacter gyrA) (Table 1)
amplified target DNA best. Quantification of the Chlamydia
cryptic plasmid amplification results could not be compared to that of
the other systems, since a different fluorophore (BTR) was used as the
reporter moiety. The results indicated that, independent of the
numbers of amplification systems present, the different primer
sets did not influence the amplification efficiency of other,
neighboring primer sets. These findings confirm the previous findings
(22) that anchored SDA primer sets act as discrete
amplification units on the microelectronic chip array.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 5.
Multiplex amplification of E. coli gyrA,
Staphylococcus mecA, Campylobacter gyrA,
C. trachomatis cryptic plasmid, and E. coli
parC. (A) Schematic representation of a multiplex
(n = 5) amplification on the microelectronic chip
array. Noncleavable (N/C) primers were included for each primer set to
control for background hybridization of template DNA. Approximately
104 copies each of E. coli,
methicillin-resistant S. aureus,
fluoroquinolone-sensitive Campylobacter, and C.
trachomatis cryptic plasmid genomic DNAs were combined
and hybridized to each amplification primer set on the microelectronic
chip array. Anchored SDA was initiated by the addition of enzymes and
bumper primers for all systems. After amplification, reporters from all
systems (wild-type and mutant reporters) were added and thermal
stringency was applied at 29°C. Images were quantified for genotype
identification of hybridized genomic DNA. (B)
Cy5 fluorescent image after thermal stringency. Note that there
is some bleed-through of the BTR signal seen in this image, due to
overlapping emission of the BTR fluorophore at this wavelength. (C) Cy3
fluorescent image after thermal stringency. Note again the
bleed-through of the BTR signal due to overlapping emission of the BTR
fluorophore at this wavelength. (D) BTR image after thermal stringency.
Quantification of signals after thermal stringency is shown in the
graph.
|
|
 |
DISCUSSION |
Anchored SDA of bacterial gene targets is an efficient method for
multiplex amplification and discrimination of antimicrobial agent-resistant strains as well as for bacterial identification. The
assay provides a specific and reliable means for culture confirmation and can be sensitive to an input level of approximately 100 copies of
DNA. It is important to note that the primer sets described here were
not optimized for either primer-primer interactions or primer
amplification efficiency. Anchored SDA allows multiplex amplification
to occur because, as has been shown previously (22), the
amplification primer sets act as discrete units on the microelectronic chip array. In anchored SDA, amplification primer sets are spatially separated, creating distinct zones of amplification that share only
enzymes and reagents. Electronic addressing of amplification primers to
distinct regions on the microchip allows a reduction in primer-primer
interactions while maintaining a completely open format that simplifies
the amplification procedure greatly. In addition to electronic
addressing, the electronic microchip format also allows electronic
hybridization, which has been shown previously to be essential for
anchored SDA of genomic DNA samples (22). Electronic hybridization may increase the efficiency of the reaction by
both facilitating strand separation of target DNA in a
low-ionic-strength environment and concentrating targets
onto the array site (5). Electronic hybridization also
confers advantages in time, allowing hybridization reactions to be
completed in minutes instead of hours (5, 8). These two
aspects, combined with the flexibility of the assay in addressing any
oligonucleotide or DNA sequence to any site on the microchip array,
make the microelectronic chip a very attractive platform for molecular
biology applications.
The flexibility of anchored SDA for bacterial identification makes it
an ideal candidate for a task- or group-specific assay design. In this
work, we have shown that five different genotypic assays (plasmid,
transposon, SNP analysis, allele-specific amplification, and
reporter-specific discrimination) can be accomplished simultaneously using anchored SDA and discrimination on the microelectronic chip platform. In the future, microchip arrays could include amplification primer sets, for example, for all known food-borne or respiratory pathogens on the same microchip, enabling amplification and
discrimination of a whole class of bacterial pathogens on a single
microchip array. In addition, anchored SDA could further discriminate,
again on the same platform, possible antimicrobial resistance markers or other genetic markers that may be present in the same sample. Anchored SDA allows many different types of assays to be
accommodated on the same platform, including RNA amplification
(22), without adjusting for special conditions such
as matching hybridization temperatures or altering stringency
conditions, as in other amplification or microchip assays. This
flexibility allows multiplex amplification and discrimination on the
same platform, potentially streamlining the development of any
nucleic-acid-based bacterial determination assay.
As demonstrated here, anchored SDA can readily discriminate SNPs. This
result suggests the immediate application of this assay for culture
confirmation in clinical laboratories. That 100 copies of DNA are
sufficient for antimicrobial resistance determination suggests
that other sample sources, including blood culture bottles, could
be used in conjunction with anchored SDA. However, increases in
sensitivity are necessary in order to analyze samples that have limited
target possibilities, including blood, sputum, or urine samples.
Studies are under way to increase the sensitivity of the assay through
optimization of amplification primer design and reagent conditions, as
well as increased amplicon retention and reporter sensitivity.
Anchored SDA incorporates amplification and detection on the same
platform. With the development of automated protocols for anchored SDA,
the process of bacterial identification could be simplified greatly by
minimizing the sample processing and transfer of amplicons needed
for other molecular biology-based assays. These features make anchored
SDA an ideal candidate for multiplex point-of-care applications.
Anchored SDA can enhance the ability of miniaturized on-site
instrumentation by decreasing the complexity of the necessary molecular
biology reactions and manipulations while simultaneously allowing
efficient multiplex amplification reactions and discrimination. Through
integration of anchored SDA into an on-site instrument, the level of
technical expertise necessary can be minimized, allowing many current
clinical laboratories access to powerful molecular biology-based assays.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge the contributions of Beth Mather,
Michael Heller, Richard Anderson, Bruce Wallace, and Douglas
Malinowski. We thank Michael Moore and Harry J. Leonhardt for
critical reading of the manuscript. We are especially grateful to
Halleh Ahadian for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Assay
Development, Nanogen, Inc., 10398 Pacific Center Ct., San Diego, CA
92121. Phone: (858) 410-4718. Fax: (858) 410-4848. E-mail:
Cmiller{at}nanogen.com.
Present address: Molecular Reflections, San Diego, Calif.
 |
REFERENCES |
| 1.
|
Cebula, T. A.,
W. L. Payne, and P. Feng.
1995.
Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR.
J. Clin. Microbiol.
33:248-250[Abstract].
|
| 2.
|
Chee, M.,
R. Yang,
E. Hubbell,
A. Berno,
X. C. Huang,
D. Stern,
J. Winkler,
D. J. Lockhart,
M. S. Morris, and S. P. Fodor.
1996.
Accessing genetic information with high-density DNA arrays.
Science
25:610-614.
|
| 3.
|
Debouck, C., and P. N. Goodfellow.
1999.
DNA microarrays in drug discovery and development.
Nat. Genet.
21:48-50[CrossRef][Medline].
|
| 4.
|
Drlica, K., and X. Zhao.
1997.
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Microbiol. Mol. Biol. Rev.
61:377-392[Abstract].
|
| 5.
|
Edman, C. F.,
D. E. Raymond,
D. J. Wu,
E. Tu,
R. G. Sosnowski,
W. F. Butler,
M. Nerenberg, and M. J. Heller.
1997.
Electric field directed nucleic acid hybridization on microchips.
Nucleic Acids Res.
25:4907-4914[Abstract/Free Full Text].
|
| 6.
|
Edman, C. F.,
P. Mehta,
R. Press,
C. A. Spargo,
G. T. Walker, and M. Nerenberg.
2000.
Pathogen analysis and genetic predisposition testing using microelectronic arrays and isothermal amplification.
J. Investig. Med.
48:93-101[Medline].
|
| 7.
|
Fredericks, D. N., and D. A. Relman.
1999.
Application of polymerase chain reaction to the diagnosis of infectious disease.
Clin. Infect. Dis.
29:475-488[Medline].
|
| 8.
|
Gilles, P. N.,
D. J. Wu,
C. B. Foster,
P. J. Dillon, and S. J. Chanock.
1999.
Single nucleotide polymorphic discrimination by an electronic dot blot assay on semiconductor microchips.
Nat. Biotechnol.
17:365-370[CrossRef][Medline].
|
| 9.
|
Gunzberg, S. T.,
N. G. Tornieporth, and L. W. Riley.
1995.
Identification of enteropathogenic Escherichia coli by PCR-based detection of the bundle-forming pilus gene.
J. Clin. Microbiol.
33:1375-1377[Abstract].
|
| 10.
|
Hatt, C.,
M. E. Ward, and I. N. Clarke.
1998.
Analysis of the entire nucleotide sequence of the cryptic plasmid of Chlamydia trachomatis serovar L1. Evidence for involvement in DNA replication.
Nucleic Acids Res.
11:4053-4067.
|
| 11.
|
Huang, W. M.
1996.
Bacterial diversity based on type II DNA topoisomerase genes.
Annu. Rev. Genet.
30:79-107[CrossRef][Medline].
|
| 12.
|
Lisby, G.
1999.
Application of nucleic acid amplification in clinical microbiology.
Mol. Biotechnol.
12:75-99[CrossRef][Medline].
|
| 13.
|
Lockhart, D. J.,
H. Dong,
M. C. Byrne,
M. Follettie,
M. V. Gallo,
M. S. Chee,
M. Mittmann,
C. Wang,
M. Kobayashi,
H. Horton, and E. L. Brown.
1996.
Expression monitoring by hybridization to high-density oligonucleotide arrays.
Nat. Biotechnol.
14:1675-1680[CrossRef][Medline].
|
| 13a.
|
National Committee for Clinical Laboratory Standards.
1999.
Molecular diagnostic methods for infectious diseases. Approved guideline MM3-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 14.
|
Parinov, S.,
V. Barsky,
G. Yershov,
E. Kirillov,
E. Timofeev,
A. Belgovskiy, and A. Mirzabekov.
1996.
DNA sequencing by hybridization to microchip octa- and decanucleotides extended by stacked pentanucleotides.
Nucleic Acids Res.
24:2998-3004[Abstract/Free Full Text].
|
| 15.
|
Patel, R.,
J. R. Uhl,
P. Kohner,
M. K. Hopkins, and F. R. Cockerill, III.
1997.
Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.
J. Clin. Microbiol.
35:703-707[Abstract].
|
| 16.
|
Pfaller, A. M., and L. A. Herwaldt.
1997.
The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology.
Clin. Infect. Dis.
25:858-870[Medline].
|
| 17.
|
Radtkey, R.,
L. Feng,
M. Muralhidar,
M. Duhon,
D. Canter,
D. DiPierro,
S. Fallon,
E. Tu,
K. McElfresh,
M. Nerenberg, and R. Sosnowski.
2000.
Rapid, high fidelity analysis of simple sequence repeats on an electronically active DNA microchip.
Nucleic Acids Res.
28:E17.
|
| 18.
|
Sosnowski, R. G.,
E. Tu,
W. F. Butler,
J. P. O'Connell, and M. J. Heller.
1997.
Rapid determination of single-base mismatch mutations in DNA hybrids by direct electric field control.
Proc. Natl. Acad. Sci. USA
94:1119-1123[Abstract/Free Full Text].
|
| 19.
|
Ubukata, K.,
S. Nakagami,
A. Nitta,
A. Yamane,
S. Kawakami,
M. Sugiura, and M. Konno.
1992.
Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products.
J. Clin. Microbiol.
30:1728-1733[Abstract/Free Full Text].
|
| 20.
|
Vannuffel, P.,
J. Gigi,
H. Ezzedine,
B. Vandercam,
M. Delmee,
G. Wauters, and J.-L. Gala.
1995.
Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR.
J. Clin. Microbiol.
33:2864-2867[Abstract].
|
| 21.
|
Walker, G. T.,
M. C. Little,
J. G. Nadeau, and D. D. Shank.
1992.
Isothermal, in vitro amplification of DNA by a restriction enzyme/DNA polymerase system.
Proc. Natl. Acad. Sci. USA
89:392-396[Abstract/Free Full Text].
|
| 22.
|
Westin, L.,
X. Xu,
C. Miller,
L. Wang,
C. F. Edman, and M. Nerenberg.
2000.
Anchored multiplex amplification on a microelectronic chip array.
Nat. Biotechnol.
18:199-204[CrossRef][Medline].
|
| 23.
|
Yershov, G.,
V. Barsky,
A. Belgovskiy,
E. Kirillov,
E. Kreindlin,
I. Ivanov,
S. Parinov,
D. Guschin,
A. Drobishev,
S. Dubiley, and A. Mirzabekov.
1996.
DNA analysis and diagnostics on oligonucleotide microchips.
Proc. Natl. Acad. Sci. USA
93:4913-4918[Abstract/Free Full Text].
|
| 24.
|
Zirnstein, G.,
Y. Li,
B. Swaminathan, and F. Angulo.
1999.
Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis.
J. Clin. Microbiol.
37:3276-3280[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, March 2001, p. 1097-1104, Vol. 39, No. 3
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.1097-1104.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sanguinetti, M., Novarese, L., Posteraro, B., Ranno, S., De Carolis, E., Pecorini, G., Lucignano, B., Ardito, F., Fadda, G.
(2005). Use of Microelectronic Array Technology for Rapid Identification of Clinically Relevant Mycobacteria. J. Clin. Microbiol.
43: 6189-6193
[Abstract]
[Full Text]
-
Lim, D. V., Simpson, J. M., Kearns, E. A., Kramer, M. F.
(2005). Current and Developing Technologies for Monitoring Agents of Bioterrorism and Biowarfare. Clin. Microbiol. Rev.
18: 583-607
[Abstract]
[Full Text]
-
Peytavi, R., Raymond, F. R., Gagne, D., Picard, F. J., Jia, G., Zoval, J., Madou, M., Boissinot, K., Boissinot, M., Bissonnette, L., Ouellette, M., Bergeron, M. G.
(2005). Microfluidic Device for Rapid (<15 min) Automated Microarray Hybridization. Clin. Chem.
51: 1836-1844
[Abstract]
[Full Text]
-
Saunders, N. A., Alexander, S., Tatt, I.
(2005). env Gene Typing of Human Immunodeficiency Virus Type 1 Strains on Electronic Microarrays. J. Clin. Microbiol.
43: 1910-1916
[Abstract]
[Full Text]
-
Xing, J. Z., Clarke, C., Zhu, L., Gabos, S.
(2005). Development of a Microelectronic Chip Array for High-Throughput Genotyping of Helicobacter Species and Screening for Antimicrobial Resistance. J Biomol Screen
10: 235-245
[Abstract]
-
Santacroce, R., Ratti, A., Caroli, F., Foglieni, B., Ferraris, A., Cremonesi, L., Margaglione, M., Seri, M., Ravazzolo, R., Restagno, G., Dallapiccola, B., Rappaport, E., Pollak, E. S., Surrey, S., Ferrari, M., Fortina, P.
(2002). Analysis of Clinically Relevant Single-Nucleotide Polymorphisms by Use of Microelectronic Array Technology. Clin. Chem.
48: 2124-2130
[Abstract]
[Full Text]
-
Hakanen, A., Jalava, J., Kotilainen, P., Jousimies-Somer, H., Siitonen, A., Huovinen, P.
(2002). gyrA Polymorphism in Campylobacter jejuni: Detection of gyrA Mutations in 162 C. jejuni Isolates by Single-Strand Conformation Polymorphism and DNA Sequencing. Antimicrob. Agents Chemother.
46: 2644-2647
[Abstract]
[Full Text]
-
Garaizar, J., Porwollik, S., Echeita, A., Rementeria, A., Herrera, S., Wong, R. M.-Y., Frye, J., Usera, M. A., McClelland, M.
(2002). DNA Microarray-Based Typing of an Atypical Monophasic Salmonella enterica Serovar. J. Clin. Microbiol.
40: 2074-2078
[Abstract]
[Full Text]